Following the 2026 NHIA Conference in Denver, Bailey Klingaman shares a brief recap of the latest news for home infusion. From market developments to events at the conference to updates on advocacy efforts, this article covers relevant news and details the home infusion and pharmacy industries.
This April, the National Home Infusion Association (NHIA) held its annual conference in Denver, CO, and it was an absolute hit. The 2024 conference had record high attendance, a theme which carried on in the 2025 event and the 2026 NHIA Conference.
With over 150 companies showcasing their products and services (including 40 first-time exhibitors) and more than 1,700 home infusion and alternate site industry professionals supporting the five-day event, the NHIA Conference was the meeting of the season.
Recently in the Home Infusion Industry
Some of the increasing participation at the NHIA Conference can be attributed to the growing home infusion market, which is linked to the aging population, integration of new technology, prevalence of chronic diseases, and the cost savings of home-based care.
Market Growth
In 2024, the U.S. home infusion therapy market was valued at $19.65 billion and is expected to reach $38.02 billion by 2032. With a compound annual growth rate (CAGR) of 8.8%, it’s fair to say that the home infusion market is quickly transitioning from a niche therapy alternative to a modern delivery model.
The National Home Infusion Foundation (NHIF) reported in 2021 that the number of home infusion patients grew by 310% from 2010 to 2019. A Becker’s Healthcare report from 2019 found approximately 3 million patients in the U.S. received home-based infusions, and considering the 3.2 million patients estimated in 2024, the need for home infusion therapy isn’t going away any time soon.
Why is the home infusion market growing?
As stated above, the home infusion therapy market is impacted by the increased demand for home-based services and widening availability of safe and effective treatments at affordable prices.
- Safety & Efficacy: Home infusion therapy is a safe alternative to hospital treatment. In 2022, the National Center for Biotechnology Information (NCBI) found that approximately 40% of infusion services could be safely and effectively administered in a patient’s home. Additionally, the CDC reported approximately 722,000 health care-associated infections occurred in U.S. acute-care hospitals in a single year, and more than 10% of those patients died during hospitalization.
- Cost Efficiency: Home-based care reduces and/or eliminates expenses like facility fees and drug markups. A 2023 NHIA Review studied six cases comparing home and inpatient treatment costs and found significant cost savings for home infusion treatment. In one case, the cost per day for home-based treatment was $122, while the inpatient cost was $798…6.5x more than the home-based therapy.
- Demographics: The CDC reports that 70% of individuals receiving home-based care in the U.S. are aged 65 and older. This demographic is expected to double from 52 million in 2018 to 95 million by 2060, representing 23% of the U.S. population. Even in the next 15 years, the Medicare Payment Advisory Commission predicts a growth of over 50% in Medicare enrollment, with beneficiaries exceeding 80 million compared to 54 million in 2015.
- Technological Advancements: The integration of technology like portable infusion devices and smart pumps contribute to safe administration of infusion therapy and remote patient management, making home infusion easier than ever before.
2026 NHIA Conference
The 2026 NHIA Conference not only includes a tradeshow/expo where organizations can network and show industry professionals a variety of innovative products designed to benefit clinicians and patients, but also features educational and timely sessions focused on learning opportunities, legislation and policy updates, and more.
This year’s conference included a general session featuring a panel of legislative and regulatory experts who discussed the latest policy updates impacting the home infusion industry. Topics centered around:
- Pharmacy Benefit Manager (PBM) practices
- New CMS models, such as IPAY, GLOBE, and GUARD
- Bills currently making their way through Capitol Hill (namely, the Preserving Patient Access to Home Infusion Act and the Joe Fiandra Access to Home Infusion Act)
Tennr & WeInfuse Happy Hour
To add a little relaxation to the mix at the 2026 NHIA Conference, Tennr & WeInfuse (two exhibitors offering technological solutions for the industry) hosted an NHIA Happy Hour on Sunday, April 19th at the Mountain Pass Sports Bar. The party was well-attended and provided exhibitors and attendees alike an opportunity to kick back and enjoy each other’s company (with a few complimentary drinks).
Exhibiting at NHIA
Following the Tennr & WeInfuse Happy Hour, the RxToolKit team spent the next two days in the exhibit hall meeting with home infusion professionals and clinicians to talk about our medication resource and clinical training software.
If you couldn’t come by the RxToolKit booth at the 2026 NHIA Conference or meet with our team to chat outside of exhibiting hours, we would still love to show you a demo of our software. Give us a call at (888)798-5548, email us at sales@rxtoolkit.com, or stay up to date with our social media (all accounts – @rxtoolkit).
What’s Next for Home Infusion
Advocacy
It’s clear that while the annual NHIA Conference is an important event facilitating communication and innovation for the industry, the Association is also working behind the scenes to make legislative improvements removing barriers impacting home infusion and its patients.
Preserving Patient Access to Home Infusion Act (H.R. 4101, S. 1976)
The Preserving Patient Access to Home Infusion Act is a bill that would modernize the Medicare home infusion benefit by:
- Removing the face-to-face requirement for billing to occur
- Expanding coverage for IV anti-infectives without requiring a pump for administration
- Reflecting the full scope of services
- Bundling disposables and supplies into the services payment
- Recognizing nurse practitioners and physician assistants in ordering home infusion therapy
Following NHIA’s annual visit to Capitol Hill this year, 10 representatives signed in support of the legislation, including Reps. Jimmy Panetta (D-CA), Paul Tonko (D-NY), Danny Davis (D-IL), Madeleine Dean (D-PA), Ted Lieu (D-CA), Doris Matsui (D-CA), Blake Moore (R-UT), Burgess Owens (R-UT), Greg Stanton (D-AZ), and Darren Soto (D-FL).
At the 2026 NHIA Conference, NHIA’s Director of Legislative Affairs Shea McCarthy stated that he is as optimistic as he’s ever been about Congress passing the Preserving Patient Access to Home Infusion Act, but that it’s likely to happen at the end of the year. In the meantime, NHIA is preparing for that opportunity and working to obtain a Congressional Budget Office score.
Joe Fiandra Access to Home Infusion Act (H.R. 5397)
The Joe Fiandra Access to Home Infusion Act is a bill that would expand the drugs and biologics under the Part B Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) external infusion pump benefit by “modifying the ‘appropriate for use in the home’ requirement for durable medical equipment,” assuming they meet the following criteria:
- The FDA prescribing information instructs that the drug associated with the pump should be administered by or under the supervision of a healthcare professional.
- A home infusion supplier either administers or supervises the administration in the patient’s home.
- The FDA prescribing information instructs that the drug be infused either at least 12 times per year or at infusion rates requiring an external pump.
The current DMEPOS benefit is limited to around 40 drugs and does not include payment for pharmacy services, a program that currently has low provider participation.
In January of this year, members of the House Energy and Commerce Health Subcommittee expressed support for the bill, and in February, government funding for Health and Human Services passed the House of Representatives, which included a change to the qualifying criteria for drugs under Medicare’s home infusion benefit.
To support the Preserving Patient Access to Home Infusion Act and/or the Joe Fiandra Access to Home Infusion Act, visit the NHIA website and write a letter to Congress in support of the bills.
Infusion & Pharmacy Software
In addition to exhibiting at the 2026 NHIA Conference and spending the week networking with home infusion and pharmacy leaders, RxToolKit, WeInfuse, and our sister company InfuseTrack also brought groundbreaking software solutions to the industry.
RxToolKit
RxToolKit includes two solutions in one software package: RxWorkFlow and RxELearning.
The RxWorkFlow platform contains an online library of user-friendly medication guides designed and maintained by our pharmacy team. Accompanied by drug-specific calculators, patient resources, and many more tools, each guide distills the lengthy medication package insert into an easy-to-navigate monograph with informative graphics, quick links, and personal note-taking abilities for users. Medications featured in our library include biologics, antibiotics, vaccines, hemophilia drugs, and oncology medications.
The RxELearning platform offers training and drug-specific assessments for clinicians to enhance clinical competency. Clinical managers can follow course progression and receive competency verification reporting to ensure comprehension. RxELearning also includes a vast selection of continuing education (CE) units provided by the Infusion Nurses Society and offers free educational access to the Immunoglobulin National Society’s library of continuing medical education (CME) units.
To learn more about RxToolKit and how it makes home infusion safer, see a demo of our software.
WeInfuse
WeInfuse is the premier technology and consulting provider for infusion therapy and medication delivery in the U.S. The WeInfuse software platform powers the end-to-end workflow for infusion centers and home infusion and specialty pharmacies nationwide.
WeInfuse’s infusion workflow management solution includes a complete pharmacy solution, which includes “easy-to-use features for automated PDMP reporting, dashboard monitoring, label customization, supply and preparation instruction templating, real-time inventory & supplies tracking, and more.”
See what WeInfuse was up to at the 2026 NHIA Conference in their “The 2026 NHIA Conference Recap: A Milestone Year for WeInfuse” blog.
InfuseTrack
RxToolKit is proud to introduce InfuseTrack, an equipment management platform for infusion operators. InfuseTrack has joined RxToolKit as part of the WeInfuse suite, which provides software solutions for every aspect of the infusion process in every place of service.
Designed for simplicity and built for healthcare, InfuseTrack helps infusion centers, specialty pharmacies, home infusion providers, and hospital outpatient departments efficiently manage infusion pumps, medical equipment, and other critical compliance needs. From real-time asset tracking and inventory monitoring to maintenance scheduling and audit-ready recordkeeping, InfuseTrack delivers the clarity, control, and confidence operators need to run a compliant and efficient equipment program.
To learn more about InfuseTrack, visit infusetrack.com.
Where to Find Us Next
Couldn’t get enough of us at the 2026 NHIA Conference or weren’t able to attend?
RxToolKit will also be exhibiting at the 2026 National Infusion Center Association (NICA) Conference in Las Vegas, NV from July 9-10. We’ll be attending the second annual, client-exclusive, live WeInfuse University Users Meeting on July 8th and invite any and all WeInfuse clients to join us. We’ll also be heading to this year’s Toast: Together for Treatment event hosted by the Infusion Access Foundation (IAF) the night of July 8th to kick off the NICA Conference.
If you won’t be attending NICA, RxToolKit will also be attending the 2026 National Association of Specialty Pharmacy (NASP) Conference in National Harbor, MD from September 22-25, and the 2026 Immunoglobulin National Society (IgNS) Conference in Las Vegas, NV from October 15-18.
We hope to see you soon!
